Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc.

Procedural entryThis page is a short order in Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc.. Read the opinion of the Court — 716 F.3d 586
Court of Appeals for the Federal Circuit·Decided September 11, 2012·No. 2012-1454·Unpublished

Opinion

NOTE: This order is nonprecedential

United States Court of Appeals for the Federal Circuit

SANOFI-AVENTIS DEUTSCHLAND GMBH, Plaintiff-Appellee, v.

GENENTECH, INC., Defendant-Appellant,

AND

BIOGEN IDEC INC., Defendant.

2012-1454

Appeal from the United States District Court for the Northern District of California in consolidated case nos. 08-CV-4909 and 09-CV-4919, Judge Susan Illston.

ON MOTION

ORDER

Genentech, Inc. moves for the court to schedule oral argument in the case in September. Sanofi-Aventis Deutschland GmbH opposes.

SANOFI-AVENTIS DEUTSCHLAND V. GENENTECH, INC. 2

By the time the motion was received by the court, the September calendar had been schedu1ed. The court previously denied a motion to expedite oral argument

Upon consideration thereof, IT Is ORDERED THAT:

The motion is denied. Oral argument will be sched- uled in the usual course.

FoR THE CoURT 1 1 /s/ J an Horbaly Date J an Horbaly Clerk cc: William E. Solander, Esq. Charles K. Verhoeven, Esq. F|\_Eg APPEA|.SFOH 826 u's.T?l%li=§-ESFSAL C\RCU\T SEP 1 1 ZUTL

JANHURBA[Y CLE¥K

Free access — add to your briefcase to read the full text and ask questions with AI

Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc., (Fed. Cir. 2012).

Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc. (Sanofi-Aventis Deutschland Gmbh v. Genentech, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.